Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual

Endocrinologia y Nutricion

Volumn 60, Issue 5, 2013, Pages 264-267

  Bergoglio, Marina T ^a   Gómez Balaguer, Marcelino ^a   Almonacid Folch, Elena ^a   Hurtado Murillo, Felipe ^a   Hernández Mijares, Antonio ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Adverse effects; Cross sex hormone therapy; Cyproterone acetate; Estrogens; Male to female transsexual; Meningioma

Indexed keywords

CYPROTERONE ACETATE; ESTRADIOL; TRIPTORELIN;

ADULT; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; HEADACHE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MALE; MALE TO FEMALE TRANSSEXUAL; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; SHORT SURVEY; VISUAL DISORDER;

ADULT; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; TRANSSEXUALISM;

EID: 84877612261     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2012.07.004     Document Type: Short Survey

References (10)

1. Hembree W., Cohen-Kettenis P., Delemarre-van de Waal H., Gooren L., Meyer W., Spack N., et al. Endocrine treatment of transsexual persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2009, 94:3132-3154.
2. Gazzeri R., Galarza M. Growth of a meningioma in a transsexual patient after estrogen-progestin therapy [letter]. N Engl J Med 2007, 357:2411-2412.
3. Delpoyi A., Han S., Parsa A. Development of a symptomatic intracranial meningioma in a male-to-female transsexual after initiation of hormone therapy. J Clin Neurosci 2010, 17:1324-1326.
4. Gooren L.J., Giltay E.J., Bunck M.C. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 2008, 93:19-25.
5. García-Malpartida K., Martin-Gorgojo A., Rocha M., Gómez-Balaguer M., Hernández Mijares A. Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transexual. Fertil Steril 2010, 94:1097.e13.
6. Wigertz A., Lonn S., Mathiesen T., Ahlbom A., Hall P., Feychting M. Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 2006, 164:629-636.
7. Wigertz S.A., Lonn A., Hall P., Auvinen A., Christensen H., Johansen C., et al. Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 2008, 17:2663-2670.
8. Froelich S., Dali-Youcef N., Boyer P., Kehrli P., Maitrot D., Auwerx J., et al. Does cyproterone acetate promote multiple meningiomas?. Endocrine abstracts of 10th European congress of endocrinology, vol. 16 2008, 158.
9. Cea-Soriano L., Blenkb T., Wallander M., García Rodríguez L. Hormonal therapies and meningiomas: is there a link?. Cancer Epidemiol 2012, 36:198-205.
10. Gil A., Oliva B., Timoner J., Maciá M., Bryant V., de Abajo F. Br J Clin Pharmacol 2011, 72:965-968.